z-logo
Premium
Localization of endothelin ETA and ETB receptor‐mediated constriction in the renal microcirculation of rats.
Author(s) -
Endlich K,
Hoffend J,
Steinhausen M
Publication year - 1996
Publication title -
the journal of physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.802
H-Index - 240
eISSN - 1469-7793
pISSN - 0022-3751
DOI - 10.1113/jphysiol.1996.sp021761
Subject(s) - vasoconstriction , afferent arterioles , microcirculation , medicine , efferent , endocrinology , endothelin receptor , constriction , arteriole , chemistry , endothelin 1 , anatomy , receptor , angiotensin ii , afferent
1. The aim of the study was to visualize endothelin‐1 (ET‐1)‐mediated constriction in renal vessels of cortical and juxtamedullary glomeruli in the split hydronephrotic rat kidney in vivo and to functionally characterize the ET receptor subtypes involved. 2. ET‐1 (10(‐9) M) constricted preglomerular vessels (by 6‐18%) and efferent arterioles (by 11‐13%), and decreased glomerular blood flow (GBF, by 55%) of cortical and juxtamedullary glomeruli. 3. The ETA antagonist BQ‐123 (10(‐6) M), as well as the ETB antagonist BQ‐788 (2 x 10(‐7) M) and IRL 1038 (10(‐6) M), shifted the concentration‐response curve of GBF for ET‐1 to the right by one order of magnitude. While BQ‐123 antagonized ET‐1 constriction only in preglomerular vessels, BQ‐788 and IRL 1038 were effective both in preglomerular vessels and efferent arterioles. 4. The ETB agonist IRL 1620 (10(‐8) M) reduced GBF by 50% and constricted efferent arterioles (by 20‐33%) about two times more than preglomerular vessels (by 6‐14%). 5. Our results suggest that in renal cortical and juxtamedullary vessels of rats, ET‐1‐induced preglomerular vasoconstriction is mediated by ETA and ETB receptors, while efferent vasoconstriction is predominantly mediated by ETB receptors, which might have important consequences for the regulation of glomerular filtration pressure by ET.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here